Anc 2024 Boston Scientific. 2024 proxy statement go to 2024 proxy statement: Boston scientific acquisition of axonics to expand urology portfolio with differentiated technologies to treat urinary and bowel dysfunction.
What is boston scientific’s forecast for 2024? Boston scientific last posted its quarterly earnings data on october 23rd, 2024.